| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HSP90 Heat-Shock Proteins | 21 | 2024 | 64 | 7.320 |
Why?
|
| Saccharomyces cerevisiae | 22 | 2024 | 540 | 4.670 |
Why?
|
| Genetic Fitness | 12 | 2023 | 30 | 4.430 |
Why?
|
| Saccharomyces cerevisiae Proteins | 15 | 2024 | 425 | 3.280 |
Why?
|
| Evolution, Molecular | 14 | 2019 | 298 | 2.490 |
Why?
|
| Mutation | 25 | 2025 | 2455 | 2.470 |
Why?
|
| Point Mutation | 11 | 2023 | 160 | 2.200 |
Why?
|
| Drug Resistance, Viral | 10 | 2025 | 156 | 2.120 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 8 | 2022 | 86 | 1.950 |
Why?
|
| Selection, Genetic | 7 | 2019 | 71 | 1.670 |
Why?
|
| HIV Protease | 5 | 2022 | 120 | 1.660 |
Why?
|
| Oseltamivir | 6 | 2022 | 34 | 1.570 |
Why?
|
| Adenosine Triphosphate | 9 | 2024 | 289 | 1.520 |
Why?
|
| Epistasis, Genetic | 5 | 2020 | 42 | 1.510 |
Why?
|
| Proteins | 8 | 2023 | 730 | 1.420 |
Why?
|
| Gene-Environment Interaction | 2 | 2021 | 48 | 1.350 |
Why?
|
| Adenosine Triphosphatases | 10 | 2024 | 253 | 1.340 |
Why?
|
| Models, Genetic | 4 | 2023 | 255 | 1.220 |
Why?
|
| Adaptation, Physiological | 4 | 2020 | 117 | 1.190 |
Why?
|
| Antiviral Agents | 8 | 2025 | 313 | 1.190 |
Why?
|
| Viral Proteins | 3 | 2022 | 253 | 1.140 |
Why?
|
| HIV-1 | 4 | 2022 | 692 | 1.090 |
Why?
|
| Models, Molecular | 17 | 2020 | 1128 | 1.050 |
Why?
|
| Protein Conformation | 12 | 2020 | 763 | 1.010 |
Why?
|
| Neuraminidase | 4 | 2022 | 43 | 0.980 |
Why?
|
| Amino Acid Substitution | 10 | 2019 | 234 | 0.910 |
Why?
|
| Ubiquitin | 5 | 2023 | 97 | 0.900 |
Why?
|
| Influenza A virus | 4 | 2022 | 116 | 0.880 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2020 | 125 | 0.870 |
Why?
|
| Molecular Chaperones | 4 | 2015 | 99 | 0.840 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 4 | 2022 | 40 | 0.800 |
Why?
|
| Protein Engineering | 6 | 2016 | 77 | 0.800 |
Why?
|
| Influenza, Human | 5 | 2022 | 192 | 0.790 |
Why?
|
| Protein Multimerization | 3 | 2015 | 169 | 0.760 |
Why?
|
| Protein Folding | 9 | 2018 | 260 | 0.740 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 15 | 0.720 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 179 | 0.620 |
Why?
|
| Drug Resistance | 4 | 2024 | 95 | 0.600 |
Why?
|
| Silent Mutation | 1 | 2018 | 5 | 0.590 |
Why?
|
| Mutagenesis | 2 | 2017 | 129 | 0.590 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2018 | 44 | 0.580 |
Why?
|
| Escherichia coli Proteins | 6 | 2007 | 264 | 0.560 |
Why?
|
| Leucine | 4 | 2025 | 61 | 0.530 |
Why?
|
| Lactams | 3 | 2025 | 18 | 0.500 |
Why?
|
| Nitriles | 3 | 2025 | 62 | 0.490 |
Why?
|
| Genes, Fungal | 2 | 2012 | 56 | 0.490 |
Why?
|
| Carrier Proteins | 5 | 2007 | 697 | 0.480 |
Why?
|
| Hydrolysis | 7 | 2015 | 141 | 0.480 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2014 | 7 | 0.460 |
Why?
|
| Ubiquitins | 1 | 2014 | 41 | 0.450 |
Why?
|
| Amino Acid Sequence | 9 | 2016 | 1553 | 0.450 |
Why?
|
| Thioredoxins | 3 | 2003 | 16 | 0.450 |
Why?
|
| Protein Binding | 12 | 2019 | 1555 | 0.440 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 333 | 0.430 |
Why?
|
| Computational Biology | 2 | 2015 | 333 | 0.420 |
Why?
|
| Endopeptidase Clp | 5 | 2007 | 35 | 0.420 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2024 | 27 | 0.420 |
Why?
|
| Fungal Proteins | 1 | 2014 | 144 | 0.420 |
Why?
|
| Bacterial Proteins | 5 | 2007 | 737 | 0.410 |
Why?
|
| Environment | 1 | 2013 | 119 | 0.410 |
Why?
|
| Genes, Essential | 1 | 2012 | 18 | 0.400 |
Why?
|
| Dogs | 7 | 2019 | 314 | 0.400 |
Why?
|
| Genetic Techniques | 1 | 2012 | 39 | 0.390 |
Why?
|
| Enzymes | 2 | 2002 | 33 | 0.380 |
Why?
|
| Humans | 29 | 2025 | 59395 | 0.380 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2018 | 263 | 0.370 |
Why?
|
| Drug Design | 2 | 2002 | 136 | 0.360 |
Why?
|
| Binding Sites | 9 | 2016 | 881 | 0.350 |
Why?
|
| Protein Structure, Quaternary | 5 | 2016 | 100 | 0.340 |
Why?
|
| Protein Stability | 3 | 2018 | 85 | 0.340 |
Why?
|
| Computer Simulation | 4 | 2011 | 459 | 0.330 |
Why?
|
| Protein Structure, Tertiary | 7 | 2013 | 656 | 0.330 |
Why?
|
| Escherichia coli | 5 | 2007 | 694 | 0.320 |
Why?
|
| Dimerization | 5 | 2014 | 144 | 0.310 |
Why?
|
| Mutant Proteins | 3 | 2016 | 103 | 0.310 |
Why?
|
| Computer-Aided Design | 2 | 2005 | 26 | 0.300 |
Why?
|
| Amino Acids | 2 | 2022 | 140 | 0.300 |
Why?
|
| Substrate Specificity | 7 | 2016 | 333 | 0.300 |
Why?
|
| Signal Transduction | 2 | 2015 | 2899 | 0.280 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2024 | 122 | 0.270 |
Why?
|
| Pyrazines | 2 | 2017 | 33 | 0.270 |
Why?
|
| Amides | 2 | 2017 | 52 | 0.270 |
Why?
|
| Serine Endopeptidases | 2 | 2004 | 84 | 0.260 |
Why?
|
| Stress, Physiological | 2 | 2020 | 185 | 0.260 |
Why?
|
| Protein Denaturation | 5 | 2019 | 67 | 0.260 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2017 | 69 | 0.260 |
Why?
|
| Circular Dichroism | 4 | 2010 | 107 | 0.250 |
Why?
|
| Madin Darby Canine Kidney Cells | 4 | 2019 | 22 | 0.250 |
Why?
|
| Adenosine Diphosphate | 2 | 2005 | 40 | 0.250 |
Why?
|
| Animals | 14 | 2019 | 19642 | 0.250 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2017 | 258 | 0.240 |
Why?
|
| RNA, Bacterial | 2 | 2004 | 68 | 0.240 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2016 | 248 | 0.240 |
Why?
|
| Cysteine Endopeptidases | 2 | 2022 | 92 | 0.240 |
Why?
|
| Protease Inhibitors | 2 | 2022 | 104 | 0.230 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2022 | 93 | 0.230 |
Why?
|
| Disulfides | 1 | 2004 | 62 | 0.230 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 347 | 0.220 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 188 | 0.220 |
Why?
|
| Phylogeny | 2 | 2018 | 337 | 0.220 |
Why?
|
| Proteolysis | 1 | 2024 | 136 | 0.220 |
Why?
|
| Genome, Viral | 2 | 2015 | 120 | 0.210 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1950 | 0.210 |
Why?
|
| Yeasts | 2 | 2014 | 51 | 0.210 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 59 | 0.200 |
Why?
|
| Endopeptidases | 1 | 2022 | 68 | 0.190 |
Why?
|
| Haemophilus influenzae | 4 | 2007 | 26 | 0.190 |
Why?
|
| Codon | 2 | 2012 | 48 | 0.190 |
Why?
|
| HIV Protease Inhibitors | 2 | 2019 | 105 | 0.190 |
Why?
|
| Solubility | 2 | 2012 | 177 | 0.180 |
Why?
|
| Catalytic Domain | 4 | 2025 | 193 | 0.180 |
Why?
|
| HEK293 Cells | 3 | 2018 | 587 | 0.180 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2011 | 74 | 0.170 |
Why?
|
| Mutation Rate | 2 | 2017 | 19 | 0.170 |
Why?
|
| Indoles | 2 | 2025 | 106 | 0.160 |
Why?
|
| Static Electricity | 3 | 2016 | 163 | 0.160 |
Why?
|
| Darunavir | 1 | 2019 | 30 | 0.160 |
Why?
|
| Genetic Code | 1 | 2019 | 6 | 0.160 |
Why?
|
| Thermodynamics | 4 | 2016 | 191 | 0.160 |
Why?
|
| Peptides | 1 | 2022 | 549 | 0.150 |
Why?
|
| RNA Folding | 1 | 2018 | 6 | 0.150 |
Why?
|
| Hydrogen Bonding | 4 | 2016 | 125 | 0.150 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1368 | 0.150 |
Why?
|
| Genetics, Population | 2 | 2017 | 40 | 0.150 |
Why?
|
| Genetic Drift | 2 | 2014 | 16 | 0.140 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 32 | 0.140 |
Why?
|
| Models, Biological | 3 | 2014 | 1142 | 0.140 |
Why?
|
| Leukemia | 1 | 2017 | 57 | 0.140 |
Why?
|
| Oncogenes | 1 | 2017 | 66 | 0.140 |
Why?
|
| Protein Structure, Secondary | 3 | 2009 | 253 | 0.140 |
Why?
|
| Mutation, Missense | 2 | 2019 | 172 | 0.140 |
Why?
|
| Cell Line | 3 | 2017 | 1983 | 0.140 |
Why?
|
| Cell Physiological Phenomena | 1 | 2017 | 12 | 0.140 |
Why?
|
| Swine | 1 | 2018 | 353 | 0.140 |
Why?
|
| Nucleotides | 2 | 2015 | 44 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 91 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 4 | 2019 | 119 | 0.130 |
Why?
|
| Virus Replication | 1 | 2018 | 305 | 0.130 |
Why?
|
| Biological Evolution | 1 | 2017 | 114 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 73 | 0.130 |
Why?
|
| CD4 Antigens | 1 | 2016 | 148 | 0.130 |
Why?
|
| Genotype | 2 | 2015 | 617 | 0.130 |
Why?
|
| Adenine | 1 | 2016 | 49 | 0.130 |
Why?
|
| Nucleosomes | 1 | 2017 | 184 | 0.130 |
Why?
|
| Conserved Sequence | 1 | 2016 | 170 | 0.120 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2016 | 130 | 0.120 |
Why?
|
| Reassortant Viruses | 1 | 2015 | 9 | 0.120 |
Why?
|
| Solvents | 1 | 2014 | 57 | 0.120 |
Why?
|
| Crystallography, X-Ray | 3 | 2019 | 424 | 0.120 |
Why?
|
| Proteomics | 1 | 2016 | 263 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 327 | 0.110 |
Why?
|
| Histones | 1 | 2017 | 456 | 0.110 |
Why?
|
| Benzoquinones | 1 | 2013 | 14 | 0.110 |
Why?
|
| Benzodioxoles | 1 | 2013 | 13 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 51 | 0.110 |
Why?
|
| Purines | 1 | 2013 | 38 | 0.110 |
Why?
|
| Lactams, Macrocyclic | 1 | 2013 | 25 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 394 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2022 | 78 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2013 | 57 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2013 | 120 | 0.100 |
Why?
|
| Cell Enlargement | 1 | 2012 | 9 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 628 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2012 | 60 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2003 | 111 | 0.100 |
Why?
|
| Gene Library | 1 | 2012 | 98 | 0.100 |
Why?
|
| Temperature | 2 | 2009 | 295 | 0.090 |
Why?
|
| DNA, Fungal | 1 | 2011 | 57 | 0.090 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 25 | 0.090 |
Why?
|
| Telomerase | 1 | 2011 | 31 | 0.090 |
Why?
|
| Phenotype | 1 | 2014 | 1137 | 0.090 |
Why?
|
| Hormones | 1 | 2011 | 60 | 0.090 |
Why?
|
| Ultracentrifugation | 1 | 2010 | 28 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 2012 | 215 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2012 | 256 | 0.090 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2009 | 2 | 0.080 |
Why?
|
| Melanoma | 1 | 2013 | 318 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2011 | 142 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 188 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 291 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 153 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 427 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2005 | 165 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 486 | 0.070 |
Why?
|
| Mice | 3 | 2017 | 10286 | 0.070 |
Why?
|
| Allosteric Site | 2 | 2023 | 31 | 0.070 |
Why?
|
| Allosteric Regulation | 2 | 2023 | 68 | 0.070 |
Why?
|
| Catalysis | 2 | 2007 | 152 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 196 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 159 | 0.060 |
Why?
|
| Bacterial Proton-Translocating ATPases | 1 | 2005 | 1 | 0.060 |
Why?
|
| Crystallization | 1 | 2005 | 97 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 88 | 0.060 |
Why?
|
| Proline | 1 | 2025 | 42 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 411 | 0.060 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 9 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2014 | 110 | 0.050 |
Why?
|
| Proteome | 1 | 2004 | 141 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 26 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 490 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1091 | 0.050 |
Why?
|
| Antibodies, Catalytic | 1 | 2002 | 1 | 0.050 |
Why?
|
| Directed Molecular Evolution | 1 | 2002 | 10 | 0.050 |
Why?
|
| Electron Microscope Tomography | 1 | 2022 | 15 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2002 | 31 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 400 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 73 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 209 | 0.050 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2001 | 31 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1151 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 90 | 0.050 |
Why?
|
| Kinetics | 1 | 2023 | 750 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 187 | 0.040 |
Why?
|
| Valine | 1 | 2019 | 31 | 0.040 |
Why?
|
| Methionine | 1 | 2019 | 53 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2019 | 45 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 689 | 0.040 |
Why?
|
| Reverse Genetics | 1 | 2019 | 10 | 0.040 |
Why?
|
| Macrophages | 2 | 2016 | 1014 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2019 | 118 | 0.040 |
Why?
|
| Software | 1 | 2001 | 366 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 445 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 91 | 0.040 |
Why?
|
| Synthetic Biology | 1 | 2017 | 14 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 140 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 617 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 178 | 0.030 |
Why?
|
| Zanamivir | 1 | 2016 | 5 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 292 | 0.030 |
Why?
|
| Biology | 1 | 2016 | 24 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 295 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 185 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2016 | 259 | 0.030 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2015 | 6 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2015 | 26 | 0.030 |
Why?
|
| Universities | 1 | 2016 | 144 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2015 | 43 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2015 | 118 | 0.030 |
Why?
|
| Students | 1 | 2016 | 202 | 0.030 |
Why?
|
| Markov Chains | 1 | 2014 | 34 | 0.030 |
Why?
|
| Viral Plaque Assay | 1 | 2013 | 16 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 805 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 88 | 0.030 |
Why?
|
| Heterografts | 1 | 2013 | 61 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 160 | 0.030 |
Why?
|
| Haemophilus Vaccines | 1 | 1992 | 5 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 74 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 472 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1992 | 43 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 1992 | 68 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 450 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 913 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1992 | 87 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1992 | 121 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 675 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 359 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 883 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 33 | 0.020 |
Why?
|
| Deuterium | 1 | 2007 | 24 | 0.020 |
Why?
|
| Guanidine | 1 | 2007 | 22 | 0.020 |
Why?
|
| Glycine | 1 | 2007 | 46 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 49 | 0.020 |
Why?
|
| Hydrogen | 1 | 2007 | 50 | 0.020 |
Why?
|
| Lysine | 1 | 2007 | 75 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 149 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2007 | 105 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 365 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 411 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 450 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2005 | 98 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 81 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 133 | 0.010 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2003 | 25 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 128 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 356 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2005 | 359 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 354 | 0.010 |
Why?
|
| Diphtheria Toxoid | 1 | 1992 | 1 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 1992 | 3 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1992 | 51 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 1992 | 31 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1992 | 173 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1992 | 147 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1992 | 513 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1992 | 218 | 0.010 |
Why?
|
| Spleen | 1 | 1992 | 479 | 0.010 |
Why?
|
| Cell Division | 1 | 1992 | 443 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1992 | 644 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1992 | 868 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1992 | 446 | 0.010 |
Why?
|
| Vaccination | 1 | 1992 | 335 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1992 | 550 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1992 | 986 | 0.000 |
Why?
|